Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy
Primary Purpose
Pancreatitis
Status
Suspended
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Boston Scientific or Cook pancreatic duct stents
Sponsored by
About this trial
This is an interventional prevention trial for Pancreatitis focused on measuring pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
Eligibility Criteria
Inclusion Criteria:
- Adult patients age 18 years of age and older
- Patients undergoing distal pancreatectomy for primary pancreatic disorder or isolated metastases to the pancreas.
Exclusion Criteria:
- Pediatric patients younger than age 18
- Pregnant patients
- Patients undergoing distal pancreatectomies performed en bloc for non- pancreatic pathologies (gastric cancer, renal cell cancer, etc).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Retrospective and prospective "non-stented"
Prospective "stented"
Arm Description
Non-stented patients undergoing distal pancreatectomy retrospectively (2008-2015) and prospectively from 2015 to 2017.
Patients who undergo prophylactic pancreatic duct stenting prior to a distal pancreatectomy starting approximately September 2015.
Outcomes
Primary Outcome Measures
Post-operative pancreatic fistula
Rate of post-operative pancreatic fistula will be evaluated at 6 months when enrollment begins. Early stop is determined under either of below conditions:
Effect size is smaller than needed to reach statistical difference even if number of enrollment is completed in one year.
Adverse events occurring from the pancreatic duct stenting itself, which include pseudocyst, delaying surgery, pancreatitis requiring prolonged hospital admission, or death.
There is statistical significant difference between control and intervention groups.
Secondary Outcome Measures
Pre-operative: Pancreatitis from pancreatic duct stent
Postoperative: Abscess, hemorrhage, reoperation, pulmonary embolism, mortality
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02573389
Brief Title
Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy
Official Title
A Pilot Study on the Effect of Transampullary Pancreatic Duct Stenting on Postoperative Pancreatic Fistula Rate After Distal Pancreatectomy
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Suspended
Why Stopped
lack of accrual due to competing study
Study Start Date
December 4, 2015 (Actual)
Primary Completion Date
December 2019 (Anticipated)
Study Completion Date
January 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Kaiser Permanente
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To determine whether pre-operative pancreatic stenting for distal pancreatectomy will impact the incidence of a post-operative pancreatic fistula, as defined by postoperative. If pre-operative pancreatic stenting appears to reduce the formation of Postoperative Pancreatic Fistula (POPF) in this pilot study, this will form the basis of a larger randomized trial in the future. The hypothesis is that pre-operative pancreatic duct stenting can significantly decrease the rate of development of a post-operative pancreatic fistula after distal pancreatectomy.
Detailed Description
Prophylactic pancreatic duct stenting is to be offered to all patients deemed a candidate for a distal pancreatectomy. This is a nonrandomized cohort study with a retrospective and prospective control group (Jan 2008 - Dec 2017 or sample size obtained) and a prospective endoscopic intervention group (September 2015 - Dec 2017 or until sample size obtained). We will then compare the rate of development of a postoperative pancreatic fistula between those patients who have preoperative stenting and those who do not. POPF will be defined as the amylase level of drain contents equaling three times or more the serum amylase on postoperative day 3, as defined by the International Study Group for Pancreatic Fistula (ISGPF) or an ICD-9 diagnosis of 577.8. The patient will have a pre-operative visit for stent placement and a post-operative visit for stent removal if still in place 4-6 weeks after distal pancreatectomy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatitis
Keywords
pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Retrospective and prospective "non-stented"
Arm Type
No Intervention
Arm Description
Non-stented patients undergoing distal pancreatectomy retrospectively (2008-2015) and prospectively from 2015 to 2017.
Arm Title
Prospective "stented"
Arm Type
Experimental
Arm Description
Patients who undergo prophylactic pancreatic duct stenting prior to a distal pancreatectomy starting approximately September 2015.
Intervention Type
Device
Intervention Name(s)
Boston Scientific or Cook pancreatic duct stents
Intervention Description
Boston Scientific or Cook straight or pigtail pancreatic stents. Stent size depends on duct size (capacity). Pancreatic plastic stents are made primarily of polyethylene materials. Pancreatic stent sizes range from 2 to 25 cm in length and 3F to 11.5F in.
Primary Outcome Measure Information:
Title
Post-operative pancreatic fistula
Description
Rate of post-operative pancreatic fistula will be evaluated at 6 months when enrollment begins. Early stop is determined under either of below conditions:
Effect size is smaller than needed to reach statistical difference even if number of enrollment is completed in one year.
Adverse events occurring from the pancreatic duct stenting itself, which include pseudocyst, delaying surgery, pancreatitis requiring prolonged hospital admission, or death.
There is statistical significant difference between control and intervention groups.
Time Frame
At 6 months when enrollment begins
Secondary Outcome Measure Information:
Title
Pre-operative: Pancreatitis from pancreatic duct stent
Time Frame
1 - 2 weeks prior to distal pancreatectomy
Title
Postoperative: Abscess, hemorrhage, reoperation, pulmonary embolism, mortality
Time Frame
3 days post surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients age 18 years of age and older
Patients undergoing distal pancreatectomy for primary pancreatic disorder or isolated metastases to the pancreas.
Exclusion Criteria:
Pediatric patients younger than age 18
Pregnant patients
Patients undergoing distal pancreatectomies performed en bloc for non- pancreatic pathologies (gastric cancer, renal cell cancer, etc).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Louis A DiFronzo, MD
Organizational Affiliation
Kaiser Permanente
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
23043660
Citation
Jin T, Altaf K, Xiong JJ, Huang W, Javed MA, Mai G, Liu XB, Hu WM, Xia Q. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB (Oxford). 2012 Nov;14(11):711-24. doi: 10.1111/j.1477-2574.2012.00531.x. Epub 2012 Aug 7.
Results Reference
background
PubMed Identifier
25392839
Citation
Schoellhammer HF, Fong Y, Gagandeep S. Techniques for prevention of pancreatic leak after pancreatectomy. Hepatobiliary Surg Nutr. 2014 Oct;3(5):276-87. doi: 10.3978/j.issn.2304-3881.2014.08.08.
Results Reference
background
Citation
3. American Society for Gastrointestinal Endoscopy (ASGE) Technology Assessment Committee. Status evaluation reports: Pancreatic and biliary stents. Gastrointest Endosc. 2013;77(3):319-327.
Results Reference
background
PubMed Identifier
24019766
Citation
Reddymasu SC, Pakseresht K, Moloney B, Alsop B, Oropezia-Vail M, Olyaee M. Incidence of pancreatic fistula after distal pancreatectomy and efficacy of endoscopic therapy for its management: results from a tertiary care center. Case Rep Gastroenterol. 2013 Aug 16;7(2):332-9. doi: 10.1159/000354136. eCollection 2013.
Results Reference
background
PubMed Identifier
20598301
Citation
Rieder B, Krampulz D, Adolf J, Pfeiffer A. Endoscopic pancreatic sphincterotomy and stenting for preoperative prophylaxis of pancreatic fistula after distal pancreatectomy. Gastrointest Endosc. 2010 Sep;72(3):536-42. doi: 10.1016/j.gie.2010.04.011. Epub 2010 Jul 3.
Results Reference
background
Learn more about this trial
Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy
We'll reach out to this number within 24 hrs